The DOI matches its Crossref record; 411 of the 411 references it cites were found in a registry or an index.
Rescuing the Last-Line Polymyxins: Achievements and Challenges
Open accessAbstract
, and Enterobacterales. Polymyxins were first discovered in the late 1940s but were abandoned soon after their approval in the late 1950s as a result of toxicities (e.g., nephrotoxicity) and the availability of "safer" antibiotics approved at that time. Therefore, knowledge on polymyxins had been scarce until recently, when enormous efforts have been made by several research teams around the world to elucidate the chemical, microbiological, pharmacokinetic/pharmacodynamic, and toxicological properties of polymyxins. One of the major achievements is the development of the first scientifically based dosage regimens for colistin that are crucial to ensure its safe and effective use in patients. Although the guideline has not been developed for polymyxin B, a large clinical trial is currently being conducted to optimize its clinical use. Importantly, several novel, safer polymyxin-like lipopeptides are developed to overcome the nephrotoxicity, poor efficacy against pulmonary infections, and narrow therapeutic windows of the currently used polymyxin B and colistin. This review discusses the latest achievements on polymyxins and highlights the major challenges ahead in optimizing their clinical use and discovering new-generation polymyxins. To save lives from the deadly infections caused by Gram negative "superbugs," every effort must be made to improve the clinical utility of the last-line polymyxins. SIGNIFICANCE STATEMENT: Antimicrobial resistance poses a significant threat to global health. The increasing prevalence of multidrug-resistant (MDR) bacterial infections has been highlighted by leading global health organizations and authorities. Polymyxins are a last-line defense against difficult-to-treat MDR Gram negative pathogens. Unfortunately, the pharmacological information on polymyxins was very limited until recently. This review provides a comprehensive overview on the major achievements and challenges in polymyxin pharmacology and clinical use and how the recent findings have been employed to improve clinical practice worldwide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 411
Bergen, P. J., Forrest, A., Bulitta, J. B., Tsuji, B. T., Sidjabat, H. E., Paterson, D. L., Li, J., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05028-11 · Cited by 128
Self-citationVelkov, T., Roberts, K. D., Nation, R. L., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb500080r · Cited by 127
Self-citationTascini, C., Tagliaferri, E., Giani, T., Leonildi, A., Flammini, S., Casini, B., Lewis, R. E., Ferranti, S., Rossolini, G. M., & Menichetti, F. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00179-13 · Cited by 127
Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin
Tan, T. Y., & Ng, S. Y. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01708.x · Cited by 126
Breazeale, S. D., Ribeiro, A. A., & Raetz, C. R. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304043200 · Cited by 124
Duperthuy, M., Binesse, J., Roux, F. L., Romestand, B., Caro, A., Got, P., Givaudan, A., Mazel, D., Bachère, E., & Destoumieux‐Garzón, D. (2010) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.02138.x · Cited by 123
A Review of the Clinical Pharmacokinetics of Polymyxin B
Avedissian, S. N., Liu, J., Rhodes, N. J., Lee, A., Pais, G. M., Hauser, A. R., & Scheetz, M. H. (2019) · Antibiotics · doi:10.3390/antibiotics8010031 · Cited by 121
Vaara, M., Siikanen, O., Apajalahti, J., Fox, J., Møller, J. K., He, H., Poudyal, A., Li, J., Nation, R. L., & Vaara, T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01439-09 · Cited by 119
Self-citationNiu, B., Vater, J., Rückert, C., Blom, J., Lehmann, M. J., Ru, J.-J., Chen, X.-H., Wang, Q., & Borriss, R. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-137 · Cited by 116
Corvec, S., Tafin, U. F., Bétrisey, B., Borens, O., & Trampuž, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01718-12 · Cited by 115
Alexis Diomedi, P. (2009) · Revista chilena de infectología · doi:10.4067/s0716-10182009000700016 · Cited by 113
Karaiskos, I., Friberg, L. E., Pontikis, K., Ioannidis, K., Tsagkari, V., Galani, L., Kostakou, E., Baziaka, F., Paskalis, C., Koutsoukou, A., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00554-15 · Cited by 113
Polymyxins and Their Potential Next Generation as Therapeutic Antibiotics
Vaara, M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01689 · Cited by 113
Bilayer Properties of Lipid A from Various Gram-Negative Bacteria
Kim, S., Patel, D. S., Park, S., Slusky, J. S. G., Klauda, J. B., Widmalm, G., & Im, W. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.09.001 · Cited by 112
Dai, C., Ciccotosto, G. D., Cappai, R., Tang, S., Li, D., Xie, S., Xiao, X., & Velkov, T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0276-6 · Cited by 112
Self-citationMegalin Contributes to Kidney Accumulation and Nephrotoxicity of Colistin
Suzuki, T., Yamaguchi, H., Ogura, J., Kobayashi, M., Yamada, T., & Iseki, K. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00254-13 · Cited by 111
Intestinal decontamination in a polyvalent ICU
Godard, J., Guillaume, C., Reverdy, M. E., et al. (1990) · Intensive Care Medicine · doi:10.1007/bf01706355 · Cited by 111
Polymyxins for CNS infections: Pharmacology and neurotoxicity
Velkov, T., Dai, C., Ciccotosto, G. D., Cappai, R., Hoyer, D., & Li, J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.07.012 · Cited by 111
Self-citationClancy, C. J., Chen, L., Hong, J. H., Cheng, S., Hao, B., Shields, R. K., Farrell, A., Doi, Y., Zhao, Y., Perlin, D. S., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01069-13 · Cited by 110
Camus, C., Bellissant, É., Sebille, V., Perrotin, D., Garo, B., Legras, A., Renault, A., Corre, P. L., Donnio, P.-Y., Gacouin, A., et al. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000152224.01949.01 · Cited by 110
Dalfino, L., Puntillo, F., Ondok, M. J. M., Mosca, A., Monno, R., Coppolecchia, S., Spada, M. L., Bruno, F., & Brienza, N. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ717 · Cited by 108
Rubin, E. J., Herrera, C. M., Crofts, A. A., & Trent, M. S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05052-14 · Cited by 107
Polymyxin B Induces Apoptosis in Kidney Proximal Tubular Cells
Azad, M. A. K., Finnin, B. A., Poudyal, A., Davis, K., Li, J., Hill, P., Nation, R. L., Velkov, T., & Li, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02587-12 · Cited by 107
Self-citationVicari, G., Bauer, S. R., Neuner, E. A., & Lam, S. W. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis909 · Cited by 107
Deris, Z. Z., Yu, H. H., Davis, K., Soon, R. L., Jacob, J., Ku, C. K., Poudyal, A., Bergen, P. J., Tsuji, B. T., Bulitta, J. B., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01064-12 · Cited by 107
Self-citationMathur, J., Davis, B. M., & Waldor, M. K. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05544.x · Cited by 106
Westerman, E. M., Brun, P. P. H. L., Touw, D. J., Frijlink, H. W., & Heijerman, H. G. M. (2004) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2003.12.005 · Cited by 106
Furtado, G. H. C., d’Azevedo, P. A., Santos, A. F., Gales, A. C., Pignatari, A. C. C., & Medeiros, E. A. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.05.017 · Cited by 104
Imberti, R., Cusato, M. P., Accetta, G., Marinò, V., Procaccio, F., Gaudio, A. D., Iotti, G. A., & Regazzi, M. B. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00231-12 · Cited by 104
p53 Is Renoprotective after Ischemic Kidney Injury by Reducing Inflammation
Sutton, T. A., Hato, T., Mai, E., Yoshimoto, M., Kuehl, S., Anderson, M. D., Mang, H. E., Plotkin, Z., Chan, R. J., & Dagher, P. C. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012050469 · Cited by 104
Anderson, D. J., Engemann, J. J., Harrell, L. J., Carmeli, Y., Reller, L. B., & Kaye, K. S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1715-1720.2006 · Cited by 102
D'Amato, R. F., Thornsberry, C., Baker, C. N., & Kirven, L. A. (1975) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.7.5.596 · Cited by 101
Morrissey, I., Olesky, M., Hawser, S., Lob, S. H., Karlowsky, J. A., Corey, G. R., Bassetti, M., & Fyfe, C. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01699-19 · Cited by 101
Comparison of three standardized disc susceptibility testing methods for colistin
Tan, T. Y. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl330 · Cited by 100
Mezzatesta, M. L., Gona, F., Caio, C., Petrolito, V., Sciortino, D., Sciacca, A., Santangelo, C., & Stefani, S. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03572.x · Cited by 99
Selective decontamination of the digestive tract in severely burned pediatric patients
Barret, J. P., Jeschke, M. G., & Herndon, D. N. (2001) · Burns · doi:10.1016/s0305-4179(00)00147-9 · Cited by 99
Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections
Brown, P., & Dawson, M. J. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2016.146 · Cited by 99
Branhamella (Neisseria) catarrhalis: criteria for laboratory identification
Doern, G. V., & Morse, S. A. (1980) · Journal of Clinical Microbiology · doi:10.1128/jcm.11.2.193-195.1980 · Cited by 98
Makris, D. A., Petinaki, E., Tsolaki, V., Manoulakas, E., Mantzarlis, K. D., Apostolopoulou, O., Sfyras, D., & Zakynthinos, E. G. (2018) · Indian Journal of Critical Care Medicine · doi:10.4103/ijccm.ijccm_302_17 · Cited by 98
Nord, N. M., & Hoeprich, P. D. (1964) · New England Journal of Medicine · doi:10.1056/nejm196405142702002 · Cited by 97
Pugin, J., Auckenthaler, R., Lew, D. P., & Suter, P. M. (1991) · PubMed · Cited by 96
Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia
Zhou, H., Yao, Y., Zhu, B., Ren, D., Yang, Q., Fu, Y., Yu, Y., & Zhou, J. (2019) · Medicine · doi:10.1097/md.0000000000014937 · Cited by 96
Tran, A. X., Lester, M. E., Stead, C. M., Raetz, C. R. H., Maskell, D. J., McGrath, S. C., Cotter, R. J., & Trent, M. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505020200 · Cited by 94
Maifiah, M. H. M., Creek, D. J., Nation, R. L., Forrest, A., Tsuji, B. T., Velkov, T., & Li, J. (2017) · Scientific Reports · doi:10.1038/srep45527 · Cited by 94
Self-citationBronchial Constriction and Inhaled Colistin in Cystic Fibrosis
Alothman, G. A., Ho, B., Alsaadi, M. M., Ho, S. L., O'Drowsky, L., Louca, E., & Coates, A. L. (2005) · CHEST Journal · doi:10.1378/chest.127.2.522 · Cited by 92
Dai, C., Ciccotosto, G. D., Cappai, R., Wang, Y., Tang, S., Hoyer, D., Schneider‐Futschik, E. K., Velkov, T., & Xiao, X. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00323 · Cited by 92
Self-citationPopulation Pharmacokinetics of Polymyxin B in Acutely Ill Adult Patients
Miglis, C. M., Rhodes, N. J., Avedissian, S. N., Kubin, C. J., Yin, M. T., Nelson, B. C., Pai, M. P., & Scheetz, M. H. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01475-17 · Cited by 92
Streptomyces Differentiation in Liquid Cultures as a Trigger of Secondary Metabolism
Manteca, Á., & Yagüe, P. (2018) · Antibiotics · doi:10.3390/antibiotics7020041 · Cited by 91
Jayol, A., Nordmann, P., Lehours, P., Poirel, L., & Dubois, V. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.06.002 · Cited by 90
Landman, D., Salamera, J., & Quale, J. M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02129-13 · Cited by 89
Renal Disposition of Colistin in the Isolated Perfused Rat Kidney
Ma, Z., Wang, J., Nation, R. L., Li, J., Turnidge, J. D., Coulthard, K. P., & Milne, R. W. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00030-09 · Cited by 89
Self-citationColistin Is Extensively Lost during Standard In Vitro Experimental Conditions
Karvanen, M., Malmberg, C., Lagerbäck, P., Friberg, L. E., & Cars, O. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00857-17 · Cited by 88
Novel derivatives of polymyxins
Vaara, M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt039 · Cited by 88
Lenhard, J. R., Smith, N. M., Bulman, Z. P., Tao, X., Thamlikitkul, V., Shin, B. S., Nation, R. L., Li, J., Bulitta, J. B., & Tsuji, B. T. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01268-16 · Cited by 88
Self-citationRahim, N. A., Cheah, S.-E., Johnson, M. D., Yu, H. H., Sidjabat, H. E., Boyce, J. D., Butler, M. S., Cooper, M. A., Fu, J. W., Paterson, D. L., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv135 · Cited by 87
Self-citationThe histamine-cytokine network in allergic inflammation
Marone, G., Granata, F., Spadaro, G., Genovese, A., & Triggiani, M. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(03)01881-5 · Cited by 87
Velkov, T., Rahim, N. A., Zhou, Q. T., Chan, H., & Li, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.11.004 · Cited by 86
Self-citationKeirstead, N. D., Wagoner, M. P., Bentley, P., Blais, M., Brown, C., Cheatham, L., Ciaccio, P. J., Dragan, Y. P., Ferguson, D., Fikes, J., et al. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft247 · Cited by 86
Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins
Lu, X., Chan, T., Xu, C., Zhu, L., Zhou, Q. T., Roberts, K. D., Chan, H., Li, J., & Zhou, F. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv340 · Cited by 86
Self-citationMolecular Mechanisms of Neurotoxicity Induced by Polymyxins and Chemoprevention
Dai, C., Xiao, X., Li, J., Ciccotosto, G. D., Cappai, R., Tang, S., Schneider‐Futschik, E. K., Hoyer, D., Velkov, T., & Shen, J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00300 · Cited by 86
Self-citationNowicki, E. M., O'Brien, J. P., Brodbelt, J. S., & Trent, M. S. (2015) · Molecular Microbiology · doi:10.1111/mmi.13018 · Cited by 85
Henry, R., Crane, B., Powell, D., Lucas, D. D., Li, Z., Aranda, J., Harrison, P. F., Nation, R. L., Adler, B., Harper, M., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku536 · Cited by 85
Self-citationQueenan, A. M., Pillar, C. M., Deane, J., Sahm, D. F., Lynch, A. S., Flamm, R. K., Peterson, J., & Davies, T. A. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.04.002 · Cited by 84
Dodd, M. E., Abbott, J., Maddison, J., Moorcroft, A. J., & Webb, A. K. (1997) · Thorax · doi:10.1136/thx.52.7.656 · Cited by 84
Al‐Sweih, N., Alhubail, M., & Rotimi, V. O. (2011) · Journal of Chemotherapy · doi:10.1179/joc.2011.23.1.13 · Cited by 83
Effects of long-term routine use of selective digestive decontamination on antimicrobial resistance
Heininger, A., Meyer, E., Schwab, F., Marschal, M., Unertl, K. E., & Krueger, W. A. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0304-5 · Cited by 83
Ventilator-associated pneumonia due to colistin susceptible-only microorganisms
Ríos, F. G., Luna, C. M., Maskin, B. C., Valiente, A., Lloria, M., Gando, S., Sosa, C., Baquero, S., Llerena, C., Petrati, C., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00156906 · Cited by 83
Pharmacokinetics and Renal Disposition of Polymyxin B in an Animal Model
Abdelraouf, K., He, J., Ledesma, K. R., Hu, M., & Tam, V. H. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01333-12 · Cited by 82
Velkov, T., Gallardo‐Godoy, A., Swarbrick, J., Blaskovich, M. A. T., Elliott, A. G., Han, M., Thompson, P. E., Roberts, K. D., Huang, J. X., Becker, B., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.01.005 · Cited by 82
Self-citationProduction of β-Lactamase Inhibitors by Streptomyces Species
Marques, D. D. A. V., Machado, S. E. F., Santos‐Ebinuma, V. C., Duarte, C. D. A. L., Converti, A., & Porto, A. L. F. (2018) · Antibiotics · doi:10.3390/antibiotics7030061 · Cited by 82
Colistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii
Charretier, Y., Diene, S. M., Baud, D., Chatellier, S., Santiago-Allexant, E., van Belkum, A., Guigon, G., & Schrenzel, J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00788-18 · Cited by 82
CHEMOTHERAPY AND PHARMACOLOGY OF AEROSPORIN
Brownlee, G., & Bushby, S. R. M. (1948) · The Lancet · doi:10.1016/s0140-6736(48)90090-7 · Cited by 81
Major Pathways of Polymyxin-Induced Apoptosis in Rat Kidney Proximal Tubular Cells
Azad, M. A. K., Akter, J., Rogers, K. L., Nation, R. L., Velkov, T., & Li, J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04869-14 · Cited by 81
Self-citationPereira, G. H., Müller, P. R., & Levin, A. S. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.01.008 · Cited by 81
Pharmacokinetics of four different brands of colistimethate and formed colistin in rats
He, H., Li, J.-C., Nation, R. L., Jacob, J., Chen, G., LEE, H. J., Tsuji, B. T., Thompson, P. E., Roberts, K., Velkov, T., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt207 · Cited by 81
Self-citationCheah, S.-E., Li, J., Tsuji, B. T., Forrest, A., Bulitta, J. B., & Nation, R. L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02927-15 · Cited by 81
Self-citationMaâlej, S., Méziou, M., Rhimi, F., & Hammami, A. (2011) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2011.03145.x · Cited by 80
SELECTIVE DECONTAMINATION IN PEDIATRIC LIVER TRANSPLANTS
RANDOMIZED, A., Smith, S. D., Jackson, R., Hannakan, C., Wadowsky, R. M., Tzakis, A. G., & Rowe, M. I. (1993) · Transplantation · doi:10.1097/00007890-199306000-00018 · Cited by 80
Gaibani, P., Lombardo, D., Lewis, R. E., Mercuri, M., Bonora, S., Landini, M. P., & Ambretti, S. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku065 · Cited by 79
Lora‐Tamayo, J., Murillo, Ó., Bergen, P. J., Nation, R. L., Poudyal, A., Luo, X., Yu, H., Ariza, J., & Li, J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku151 · Cited by 78
Self-citationResistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China
Lin, J., Xu, C., Fang, R., Cao, J., Zhang, X., Zhao, Y., Dong, G., Sun, Y., & Zhou, T. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00556-19 · Cited by 78
Oostdijk, E. A. N., de Smet, A. M. G. A., Kesecioğlu, J., & Bonten, M. J. M. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318208ee26 · Cited by 77
Pantopoulou, A., Giamarellos‐Bourboulis, E. J., Raftogannis, M., Τσαγανός, Θ., Dontas, I. A., Koutoukas, P., Baziaka, F., Giamarellou, H., & Perrea, D. N. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.09.009 · Cited by 77
Eichhorn, I., Feudi, C., Wang, Y., Kaspar, H., Feßler, A. T., Lübke‐Becker, A., Michael, G. B., Shen, J., & Schwarz, Š. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx538 · Cited by 77
Brochmann, R. P., Toft, A. D., Ciofu, O., Briales, A., Kolpen, M., Hempel, C., Bjarnsholt, T., Høiby, N., & Jensen, P. Ø. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.10.015 · Cited by 75
Waites, K. B., Canupp, K. C., Roper, J. F., Camp, S. M., & Chen, Y. (2006) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2006.11753877 · Cited by 74
Lin, Y.-W., Zhou, Q. T., Onufrak, N. J., Wirth, V., Chen, K., Wang, J., Forrest, A., Chan, H., & Li, J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00211-17 · Cited by 74
Self-citationAzad, M. A. K., Roberts, K. D., Yu, H. H., Liu, B., Schofield, A. V., James, S., Howard, D. L., Nation, R. L., Rogers, K. L., de Jonge, M. D., et al. (2015) · Analytical Chemistry · doi:10.1021/ac504516k · Cited by 72
Self-citationHan, M., Zhu, Y., Creek, D. J., Lin, Y., Gutu, A. D., Hertzog, P. J., Purcell, T., Shen, H., Moskowitz, S. M., Velkov, T., et al. (2019) · mSystems · doi:10.1128/msystems.00149-18 · Cited by 71
Self-citationKasiakou, S. K., Rafailidis, P. I., Liaropoulos, K., & Falagas, M. E. (2004) · Journal of Infection · doi:10.1016/j.jinf.2004.05.008 · Cited by 70
Suh, J.-Y., Son, J. S., Chung, D. R., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00762-09 · Cited by 70
Schülin, T. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.2.403 · Cited by 70
Preliminary Clinical Study of the Effect of Ascorbic Acid on Colistin-Associated Nephrotoxicity
Sirijatuphat, R., Limmahakhun, S., Sirivatanauksorn, V., Nation, R. L., Li, J., & Thamlikitkul, V. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00280-15 · Cited by 69
Self-citationLee, S. Y., Shin, J. H., Lee, K., Joo, M. Y., Park, K. H., Shin, M., Suh, S., Ryang, D. W., & Kim, S. H. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00427-13 · Cited by 69
pAMβ1 resolvase has an atypical recombination site and requires a histone‐like protein HU
Petit, M., Ehrlich, S. D., & Jannière, L. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.mmi_18020271.x · Cited by 69
Effect of Polymyxin B Sulfate on Endotoxin Activity in a Gram-Negative Septicemia Model
Corrigan, J. J., & Kiernat, J. F. (1979) · Pediatric Research · doi:10.1203/00006450-197901000-00011 · Cited by 68
An Inner Membrane Dioxygenase that Generates the 2-Hydroxymyristate Moiety of Salmonella Lipid A
Gibbons, H. S., Reynolds, C. M., Guan, Z., & Raetz, C. R. H. (2008) · Biochemistry · doi:10.1021/bi702457c · Cited by 68
Pneumatikos, I. A., Koulouras, V., Nathanail, C., Goe, D., & Nakos, G. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1238-1 · Cited by 68
Μάρκου, Ν., Fousteri, M., Markantonis, S. L., Zidianakis, B., Hroni, D., Boutzouka, E. G., & Baltopoulos, G. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks257 · Cited by 68
Mogi, T., Murase, Y., Mori, M., Shiomi, K., Ōmura, S., Paranagama, M. P., & Kita, K. (2009) · The Journal of Biochemistry · doi:10.1093/jb/mvp096 · Cited by 68
Imaging the distribution of polymyxins in the kidney
Yun, B., Azad, M. A. K., Wang, J., Nation, R. L., Thompson, P. E., Roberts, K. D., Velkov, T., & Li, J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku441 · Cited by 68
Self-citationMoskowitz, S. M., Garber, E., Chen, Y., Clock, S. A., Tabibi, S., Miller, A. K., Doctor, M., & Saiman, L. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq131 · Cited by 65
Williams, G. J., Breazeale, S. D., Raetz, C. R. H., & Naismith, J. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501534200 · Cited by 64
Dai, C., Tang, S., Velkov, T., & Xiao, X. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9396-7 · Cited by 63
Self-citationde Smet, A. M. G. A., Hopmans, T. E. M., Minderhoud, A. L. C., Blok, H. E. M., Gossink, A., Bernards, A. T., & Bonten, M. J. M. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1554-9 · Cited by 63
Betts, J. W., Phee, L. M., Hornsey, M., Woodford, N., & Wareham, D. W. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02449-14 · Cited by 63
Impact of digestive and oropharyngeal decontamination on the intestinal microbiota in ICU patients
Benus, R. F., Harmsen, H. J., Welling, G. W., Spanjersberg, R., Zijlstra, J. G., Degener, J. E., & van der Werf, T. S. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1826-4 · Cited by 63
CrrB Positively Regulates High-Level Polymyxin Resistance and Virulence in Klebsiella pneumoniae
McConville, T. H., Annavajhala, M. K., Giddins, M. J., Maćešić, N., Herrera, C. M., Rozenberg, F. D., Bhushan, G. L., Ahn, D. S., Mancia, F., Trent, M. S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108313 · Cited by 62
Shifting patterns of inhaled antibiotic use in cystic fibrosis
Moskowitz, S. M., Silva, S. J., Mayer-Hamblett, N., Pasta, D. J., Mink, D. R., Mabie, J. A., Konstan, M. W., & Wagener, J. S. (2008) · Pediatric Pulmonology · doi:10.1002/ppul.20873 · Cited by 61
Vourli, S., Dafopoulou, K., Vrioni, G., Tsakris, A., & Pournaras, S. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx186 · Cited by 61
Impact of the colistin resistance gene mcr-1 on bacterial fitness
Tietgen, M., Semmler, T., Riedel-Christ, S., Kempf, V. A. J., Molinaro, A., Ewers, C., & Göttig, S. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.11.011 · Cited by 61
Lucas, D. D., Crane, B., Wright, A., Han, M., Moffatt, J. H., Bulach, D., Gladman, S. L., Powell, D., Aranda, J., Seemann, T., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02442-17 · Cited by 61
Self-citationCompounded Colistimethate as Possible Cause of Fatal Acute Respiratory Distress Syndrome
McCoy, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmc071717 · Cited by 60
Serratia marcescens arn , a PhoP-Regulated Locus Necessary for Polymyxin B Resistance
Lin, Q. Y., Tsai, Y.-L., Liu, M.-C. J., Lin, W.-C., Hsueh, P., & Liaw, S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00013-14 · Cited by 60
Ruza, F., Alvarado, F., Herruzo, R., Delgado, M. A., García, S. G., Dorao, P., & Goded, F. (1998) · European Journal of Epidemiology · doi:10.1023/a:1007487330893 · Cited by 59
Kuo, S., Lee, Y.-T., Yang, S.-P., Chen, C.-P., Chen, T.-L., Hsieh, S.-L., Siu, L.-K. K., & Fung, C. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03682.x · Cited by 58
Genomic Analysis of a Pan-Resistant Isolate of Klebsiella pneumoniae , United States 2016
de Man, T. J. B., Lutgring, J. D., Lonsway, D. R., Anderson, K. F., Kiehlbauch, J. A., Chen, L., Walters, M. S., Sjölund-Karlsson, M., Rasheed, J. K., Kallen, A. J., et al. (2018) · mBio · doi:10.1128/mbio.00440-18 · Cited by 58
Souli, M., Rekatsina, P. D., Chryssouli, Z., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01271-08 · Cited by 57
Nilsson, A., Goodwin, R. J. A., Swales, J. G., Gallagher, R. T., Shankaran, H., Sathe, A. G., Pradeepan, S., Xue, A., Keirstead, N. D., Sasaki, J. C., et al. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00262 · Cited by 56
Lin, C.-C., Liu, T.-C., Kuo, C.-F., Liu, C.-P., & Lee, C.-M. (2010) · Journal of Microbiology Immunology and Infection · doi:10.1016/s1684-1182(10)60050-3 · Cited by 56
Conole, D., & Keating, G. M. (2014) · Drugs · doi:10.1007/s40265-014-0181-0 · Cited by 56
Ochoa-Ardila, M. E., García-Cañas, A., Gómez-Mediavilla, K., González-Torralba, A., Alía, I., García-Hierro, P., Taylor, N., van Saene, H. K. F., & de la Cal, M. A. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2307-0 · Cited by 55
Sorlí, L., Luque, S., Li, J., Campillo, N., Danés-Castells, M., Montero, M., Segura, C., Grau, S., & Horcajada, J. P. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.06.011 · Cited by 55
Self-citationPogue, J. M., Jones, R. N., Bradley, J. S., Andes, D. R., Bhavnani, S. M., Drusano, G. L., Dudley, M. N., Flamm, R. K., Rodvold, K. A., & Ambrose, P. G. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01495-19 · Cited by 55
Jiang, X., Yang, K., Yuan, B., Han, M., Zhu, Y., Roberts, K. D., Patil, N. A., Li, J., Gong, B., Hancock, R. E. W., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa376 · Cited by 55
Self-citationNg, T. M., Teng, C. B., Lye, D. C., & Apisarnthanarak, A. (2013) · Infection Control and Hospital Epidemiology · doi:10.1086/674387 · Cited by 54
Susceptibility of Beta-Hemolytic Streptococci to 65 Antibacterial Agents
Finland, M., Garner, C., Wilcox, C., & Sabath, L. D. (1976) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.9.1.11 · Cited by 54
Kim, S.-H., Jia, W., Parreira, V. R., Bishop, R. E., & Gyles, C. L. (2006) · Microbiology · doi:10.1099/mic.0.28692-0 · Cited by 53
Cirioni, O., Ghiselli, R., Silvestri, C., Kamysz, W., Orlando, F., Mocchegiani, F., Matteo, F. D., Riva, A., Łukasiak, J., Scalise, G., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01576-06 · Cited by 53
Karaiskos, I., Galani, L., Baziaka, F., Katsouda, E., Ioannidis, I., Andreou, A., Paskalis, H., & Giamarellou, H. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.02.010 · Cited by 52
Choi, H., Kim, K., Han, J., Choi, H. J., Jin, S. H., Lee, E. K., Shin, D. W., Lee, T. R., Lee, A., & Noh, M. (2012) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.03.002 · Cited by 52
Suzuki, T., Hayashi, K., Fujikawa, K., & Tsukamoto, K. (1965) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a128082 · Cited by 52
Buyck, J. M., Tulkens, P. M., & Françoise Van Bambeke, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02609-12 · Cited by 52
The in-vitro activity of colistin in gram-negative bacteria.
Tan, T. Y., & Ng, S. Y. (2006) · PubMed · Cited by 51
Potential Toxicity of Polymyxins in Human Lung Epithelial Cells
Ahmed, M. U., Velkov, T., Lin, Y., Yun, B., Nowell, C. J., Zhou, F., Zhou, Q. T., Chan, K. H., Azad, M. A. K., & Li, J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02690-16 · Cited by 51
Self-citationYılmaz, E. M., Sünbül, M., Aksoy, A., Yılmaz, H., Güney, A. K., & Güvenç, T. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.06.003 · Cited by 50
Ribera, A., Benavent, E., Lora-Tamayo, J., Tubau, F., Pedrero, S., Cabo, X., Ariza, J., & Murillo, Ó. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv281 · Cited by 50
Cell cycle arrest in a model of colistin nephrotoxicity
Eadon, M. T., Hack, B. K., Alexander, J. J., Xu, C., Dolan, M. E., & Cunningham, P. N. (2013) · Physiological Genomics · doi:10.1152/physiolgenomics.00076.2013 · Cited by 49
Polymyxin B Moderates Acidosis and Hypotension in Established, Experimental Gram-Negative Septicemia
Flynn, P. M., Shenep, J. L., Stokes, D. C., Fairclough, D. L., & Hildner, W. K. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/156.5.706 · Cited by 48
Hussein, M. H., Han, M., Zhu, Y., Zhou, Q. T., Lin, Y.-W., Hancock, R. E. W., Hoyer, D., Creek, D. J., Li, J., & Velkov, T. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01587-19 · Cited by 47
Self-citationJiang, X., Yang, K., Han, M., Yuan, B., Li, J., Gong, B., Velkov, T., Schreiber, F., Wang, L., & Li, J. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00330 · Cited by 47
Self-citationInhaled colistin for lower respiratory tract infections
Antoniu, S. A., & Cojocaru, I. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.660480 · Cited by 46
Cheong, H. S., Kim, S. Y., Wi, Y. M., Peck, K. R., & Ko, K. S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091444 · Cited by 45
Zhu, Y., Zhao, J., Maifiah, M. H. M., Velkov, T., Schreiber, F., & Li, J. (2019) · mSystems · doi:10.1128/msystems.00157-18 · Cited by 44
Self-citationShimizu, T., Miyake, T., & Tani, M. (2017) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12015 · Cited by 43
Jin, L., Li, J., Nation, R. L., & Nicolazzo, J. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01273-10 · Cited by 42
Self-citationBetts, J. W., Phee, L. M., Woodford, N., & Wareham, D. W. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2101-3 · Cited by 42
Ku, Y.-H., Chen, C.-C., Lee, M.-F., Chuang, Y.-C., Tang, H.-J., & Yu, W. (2017) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2016.12.008 · Cited by 42
Dalgıç, N., Ceylan, Y., Sancar, M., Telhan, L., Kafadar, İ., Çavuşoğlu, H. A., Ceylan, Ö., & Hasim, O. (2009) · Annals of Tropical Paediatrics · doi:10.1179/146532809x440761 · Cited by 41
Melsen, W. G., de Smet, A. M. G. A., Kluytmans, J. A. J. W., & Bonten, M. J. M. (2011) · British journal of surgery · doi:10.1002/bjs.7703 · Cited by 41
Moland, E. S., Craft, D. W., Chong, Y., Kim, S.-Y., Hachmeister, L., Sayed, S. D., & Thomson, K. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01581-07 · Cited by 41
Novel polymyxin derivatives are less cytotoxic than polymyxin B to renal proximal tubular cells
Mingeot‐Leclercq, M., Tulkens, P. M., Denamur, S., Vaara, T., & Vaara, M. (2012) · Peptides · doi:10.1016/j.peptides.2012.03.033 · Cited by 41
Polymyxins and Doripenem Combination Against KPC-Producing Klebsiella pneumoniae
Lee (2013) · Journal of Clinical Medicine Research · doi:10.4021/jocmr1220w · Cited by 41
Deciphering Heteroresistance to Colistin in a Klebsiella pneumoniae Isolate from Marseille, France
Bardet, L., Baron, S. A., Leangapichart, T., Okdah, L., Diene, S. M., & Rolain, J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00356-17 · Cited by 41
Lu, Z., Jiang, G., Chen, Y., Wang, J., Ishfaq, M., Zhang, L., Wang, R., Liu, F., Li, R., Qian, F., et al. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.04.027 · Cited by 40
Self-citationTHE CHEMOTHERAPY AND PHARMACOLOGY OF THE POLYMYXINS
BROWNLEE, G., Bushby, S. R. M., & Short, E. I. (1952) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1952.tb00702.x · Cited by 39
Role of Heme Oxygenase-1 in Polymyxin B-Induced Nephrotoxicity in Rats
da Fonseca, C. D., Watanabe, M., & Vattimo, M. D. F. F. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00925-12 · Cited by 39
Di, X., Wang, R., Liu, B., Zhang, X., Ni, W., Wang, J., Liang, B., Cai, Y., & Liu, Y.-N. (2015) · The Journal of Antibiotics · doi:10.1038/ja.2015.27 · Cited by 39
Park, G. C., Choi, J. A., Jang, S. J., Jeong, S. H., Kim, C., Choi, I. S., Kang, S. H., Park, G., & Moon, D. S. (2015) · Annals of Laboratory Medicine · doi:10.3343/alm.2016.36.2.124 · Cited by 39
Jm, M., Mj, K., & Quie, P. G. (1969) · PubMed · Cited by 38
Hurley, J. C., Guidet, B., Offenstadt, G., & Maury, É. (2012) · Critical Care · doi:10.1186/cc11462 · Cited by 38
Walsh, C. C., Landersdorfer, C. B., McIntosh, M. P., Peleg, A. Y., Hirsch, E. B., Kirkpatrick, C. M. J., & Bergen, P. J. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw115 · Cited by 38
Mattos, K. P. H., Cintra, M. L., Gouvêa, I. R., Ferreira, L. Á., Velho, P. E. N. F., & Moriel, P. (2017) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12543 · Cited by 38
Srinivas, P., Hunt, L., Pouch, S. M., Thomas, K., Goff, D. A., Pancholi, P., Balada-Llasat, J.-M., & Bauer, K. A. A. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.01.028 · Cited by 38
Tetteroo, G. W. M., Wagenvoort, J. H. T., Mulder, P. G. H., et al. (1993) · Critical Care Medicine · doi:10.1097/00003246-199311000-00018 · Cited by 37
Discovery of Novel Polymyxin-Like Antibiotics
Velkov, T., & Roberts, K. D. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-16373-0_20 · Cited by 37
Self-citationInhaled Colistin for Treatment of Pneumonia due to Colistin-Only-SusceptibleAcinetobacter baumannii
Choi, H. K., Kim, Y. K., Kim, H. Y., & Uh, Y. (2013) · Yonsei Medical Journal · doi:10.3349/ymj.2014.55.1.118 · Cited by 36
Barcelos, R. P., Bresciani, G., Rodriguez‐Miguelez, P., Cuevas, M. J., Soares, F. A. A., Barbosa, N. V., & González‐Gallego, J. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.006 · Cited by 36
Effects of colistin on amino acid neurotransmitters and blood-brain barrier in the mouse brain
Wang, J., Yi, M., Chen, X., Ishfaq, M., Liu, F., Li, R., Li, J., & Li, J. (2016) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2016.03.004 · Cited by 35
Self-citationHsieh, T.-C., Chen, F.-L., Ou, T.-Y., Jean, S., & Lee, W. (2014) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2014.08.009 · Cited by 34
Jin, L., Nation, R. L., Li, J., & Nicolazzo, J. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00765-13 · Cited by 34
Self-citationNastro, M., Rodríguez, C. H., Monge, R., Zintgraff, J. C., Neira, L., Rebollo, M., Vay, C. A., & Famiglietti, A. M. R. (2013) · Journal of Chemotherapy · doi:10.1179/1973947813y.0000000136 · Cited by 33
Acquired skin hyperpigmentation following intravenous polymyxin B treatment: a cohort study
Mattos, K. P. H., Lloret, G. R., Cintra, M. L., Gouvêa, I. R., Rodrigues, T. B., Mazzola, P. G., & Moriel, P. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12468 · Cited by 33
Rigatto, M. H., Ribeiro, V. B., Konzen, D., & Zavascki, A. P. (2012) · Infection · doi:10.1007/s15010-012-0349-z · Cited by 32
Salazar, J., Alarcón, M., Huerta, J., Navarro, B., & Aguayo, D. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.03.008 · Cited by 32
Polymyxin B causes DNA damage in HK-2 cells and mice
Yun, B., Zhang, T., Azad, M. A. K., Wang, J., Nowell, C. J., Kalitsis, P., Velkov, T., Hudson, D. F., & Li, J. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2192-1 · Cited by 32
Self-citationVaara, M., Sader, H. S., Rhomberg, P. R., Jones, R., & Vaara, T. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks438 · Cited by 31
Govaerts, C., Orwa, J., Schepdael, A. V., et al. (2002) · Journal of Chromatography A · doi:10.1016/s0021-9673(02)00375-8 · Cited by 30
Structure–activity studies on novel polymyxin derivatives that carry only three positive charges
Vaara, M., & Vaara, T. (2010) · Peptides · doi:10.1016/j.peptides.2010.09.010 · Cited by 30
Lundberg, C. V., Vaara, T., Frimodt‐Møller, N., & Vaara, M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq072 · Cited by 30
Shirawi, N., Memish, Z. A., Cherfan, A. J., & Shimemeri, A. A. (2006) · Journal of Chemotherapy · doi:10.1179/joc.2006.18.5.554 · Cited by 29
Nation, R. L., & Forrest, A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-16373-0_15 · Cited by 28
Nakamura, T., Komatsu, M., Yamasaki, K., Fukuda, S., Higuchi, T., Ono, T., Nishio, H., Sueyoshi, N., Kida, K., Satoh, K., et al. (2013) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2013.08.004 · Cited by 26
Kroeger, L. A., Hovde, L. B., Mitropoulos, I. F., Schafer, J. A., & Rotschafer, J. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01433-06 · Cited by 26
Biagi, M. J., Butler, D. A., Tan, X., Qasmieh, S., & Wenzler, E. (2019) · Antibiotics · doi:10.3390/antibiotics8010027 · Cited by 25
Jung, S., Chung, E. K., Jun, M. S., Son, E. S., & Rhie, S. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-44965-y · Cited by 25
Anti-endotoxin Properties of Polymyxin B-immobilized Fibers
Tani, T., Shimizu, T., Tani, M., Shoji, H., & Endo, Y. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-16373-0_19 · Cited by 25
Wang, C.-C., Chao, T.-Y., Chen, Y., Fang, W., Kao, H., Chen, H., Tsai, Y.-C., Shen, L.-S., Li, C.-L., Chang, H., et al. (2014) · Biomedical Journal · doi:10.4103/2319-4170.132879 · Cited by 24
Sandle, T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-100022-9.00014-1 · Cited by 24
Tängdén, T., Karvanen, M., Friberg, L. E., Odenholt, I., & Cars, O. (2017) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2017.1296183 · Cited by 24
Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
Blaskovich, M. A. T., Pitt, M. E., Elliott, A. G., & Cooper, M. A. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1483240 · Cited by 24
Comparative evaluation of the UMIC Colistine kit to assess MIC of colistin of gram-negative rods
Bardet, L., Okdah, L., Page, S. L., Baron, S. A., & Rolain, J. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1424-8 · Cited by 23
Lin, Y., Rahim, N. A., Zhao, J., Han, M., Yu, H. H., Wickremasinghe, H., Chen, K., Wang, J., Paterson, D. L., Zhu, Y., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02176-18 · Cited by 23
Self-citationPulmonary Pharmacokinetics of Colistin following Administration of Dry Powder Aerosols in Rats
Lin, Y.-W., Zhou, Q. T., Hu, Y., Onufrak, N. J., Sun, S., Wang, J., Forrest, A., Chan, H., & Li, J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00973-17 · Cited by 22
Self-citationValour, F., Dutronc, H., Dinh, A., Cazorla, C., Pavèse, P., Lesens, O., Uçkay, İ., Chidiac, C., & Ferry, T. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.09.016 · Cited by 21
Hanasawa, K., Tani, T., Oka, T., Yoshioka, T., Aoki, H., Endo, Y., & Kodama, M. (1988) · PubMed · Cited by 21
Lin, Y., Han, M., Zhao, J., Zhu, Y., Rao, G. G., Forrest, A., Song, J., Kaye, K. S., Hertzog, P. J., Purcell, A. W., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01146 · Cited by 21
Self-citationKuck, N. A. (1976) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.9.3.493 · Cited by 20
Sun, H., Shields, R. K., Cacciarelli, T. V., Muder, R. R., & Singh, N. (2010) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2010.00543.x · Cited by 20
Jin, L., Li, J., Nation, R. L., & Nicolazzo, J. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00713-12 · Cited by 19
Self-citation
Cited by
Tolerance and resistance of microbial biofilms
Ciofu, O., Moser, C., Jensen, P. Ø., & Høiby, N. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00682-4 · Cited by 1,124
Klebsiella pneumoniae carbapenemase variants: the new threat to global public health
Ding, L., Shen, S., Chen, J., Tian, Z., Shi, Q., Han, R., Guo, Y., & Hu, F. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-23 · Cited by 222
Lipopeptide antibiotics disrupt interactions of undecaprenyl phosphate with UptA
Oluwole, A. O., Kalmankar, N. V., Guida, M., Bennett, J. L., Poce, G., Bolla, J. R., & Robinson, C. V. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2408315121 · Cited by 13
Metadata
- Authors
- Nang, S. C., Azad, M. A. K., Velkov, T., Zhou, Q. (., & Li, J.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 73
- Issue
- 2
- Pages
- 679-728
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W3131147063
- Cited by
- 421
- References
- 411
- FWCI
- 17.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.